The SERPINA4 rs2070777 AA Genotype is Associated with an Increased Risk of Recurrent Miscarriage in a Southern Chinese Population

References

• Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368(9535):601–611. doi:10.1016/S0140-6736(06)69204-0
   PubMed Web of Science ®Google Scholar
• Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2:76–83.
   PubMedGoogle Scholar
• Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W. Thaler CJ and Makrigiannakis A. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010;85(1):25–32. doi:10.1016/j.jri.2009.12.006
   PubMed Web of Science ®Google Scholar
• Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR. Gueuvoghlanian-Silva BY and Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am j Reproduct Immunology. 2012;67(4):341–347. doi:10.1111/j.1600-0897.2012.01123.x
   PubMed Web of Science ®Google Scholar
• Muyayalo KP, Li ZH, Mor G, Liao A-H. Mor G and Liao AH. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion. Am j Reproduct Immunology. 2018;80(4):e13018. doi:10.1111/aji.13018
   Web of Science ®Google Scholar
• Grimstad F, Krieg S. Immunogenetic contributions to recurrent pregnancy loss. J Assist Reprod Genet. 2016;33(7):833–847. doi:10.1007/s10815-016-0720-6
   Web of Science ®Google Scholar
• Najafi S, Hadinedoushan H, Eslami G, Aflatoonian A. Eslami G and Aflatoonian A. Association of IL-17A and IL-17 F gene polymorphisms with recurrent pregnancy loss in Iranian women. J Assist Reprod Genet. 2014;31(11):1491–1496. doi:10.1007/s10815-014-0294-0
   PubMed Web of Science ®Google Scholar
• Ali Rahmani S. Paknejad Z and Mohammadkhanlou M. The effects of tumor necrosis factor-alpha (TNF-alpha) and IL-1 receptor antagonist (IL-1Ra) polymorphisms on recurrent abortion in Azari women. Ginekol Pol. 2017;88:421–427.
   Web of Science ®Google Scholar
• Bahadori M, Zarei S, Zarnani AH, et al. 6, IL-10 and IL-17 gene polymorphisms in Iranian women with recurrent miscarriage. Iranian j Immunology. 2014;11:97–104.
   PubMed Web of Science ®Google Scholar
• Ahmed SK, Mahmood N, Malalla ZH, Alsobyani FM, Al-Kiyumi IS, Almawi WY. Al-Kiyumi IS and Almawi WY. C-reactive protein gene variants associated with recurrent pregnancy loss independent of CRP serum levels: a case-control study. Gene. 2015;569(1):136–140. doi:10.1016/j.gene.2015.05.052
   PubMed Web of Science ®Google Scholar
• Almawi WY, Saldanha FL, Mahmood NA, Al-Zaman I, Sater MS, Mustafa FE. Sater MS and Mustafa FE. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. Human Reproduction. 2013;28(10):2628–2635. doi:10.1093/humrep/det308
   PubMed Web of Science ®Google Scholar
• Chao J, Schmaier A, Chen LM, Yang Z, Chao L. Yang Z and Chao L. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J Lab Clin Med. 1996;127(6):612–620. doi:10.1016/S0022-2143(96)90152-3
   PubMed Web of Science ®Google Scholar
• Chao J, Li P, Chao L. Li P and Chao L. Kallistatin suppresses cancer development by multi-factorial actions. Crit Rev Oncol Hematol. 2017;113:71–78. doi:10.1016/j.critrevonc.2017.03.011
   Web of Science ®Google Scholar
• Chao J, Li P, Chao L. Li P and Chao L. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. Biol Chem. 2017;398(12):1309–1317. doi:10.1515/hsz-2017-0180
   Web of Science ®Google Scholar
• Li J. Krishna SM and Golledge J. The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm. Int J Mol Sci. 2016;17.
   Web of Science ®Google Scholar
• Chao J, Miao RQ, Chen V, Chen L-M, Chao L. Chen LM and Chao L. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Biol Chem. 2001;382(1):15–21. doi:10.1515/BC.2001.003
   Web of Science ®Google Scholar
• Lin WC, Chen CW, Huang YW, Chao L, Chao J. Lin YS and Lin CF. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Sci Rep. 2015;5:12463. doi:10.1038/srep12463
   PubMed Web of Science ®Google Scholar
• Huang KF, Yang HY, Xing YM, Lin JS, Diao Y. Lin JS and Diao Y. Recombinant human kallistatin inhibits angiogenesis by blocking VEGF signaling pathway. J Cell Biochem. 2014;115(3):575–584. doi:10.1002/jcb.24693
   Web of Science ®Google Scholar
• Li P, Guo Y, Bledsoe G, Yang Z, Chao L, Chao J. Chao L and Chao J. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis. Exp Cell Res. 2016;340(2):305–314. doi:10.1016/j.yexcr.2016.01.004
   PubMed Web of Science ®Google Scholar
• Li D, Li J. Association of miR-34a-3p/5p, miR-141-3p/5p, and miR-24 in Decidual Natural Killer Cells with Unexplained Recurrent Spontaneous Abortion. Med Sci Monitor. 2016;22:922–929. doi:10.12659/MSM.895459
   PubMed Web of Science ®Google Scholar
• Magdoud K, Herbepin VG, Touraine R. Almawi WY and Mahjoub T. Plasminogen activator inhibitor 1 4G/5G and −844G/A variants in idiopathic recurrent pregnancy loss. Am j Reproduct Immunology. 2013;70:246–252. doi:10.1111/aji.12116
   Web of Science ®Google Scholar
• Chao J, Bledsoe G, Chao L. Bledsoe G and Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. 2016;68(3):533–541. doi:10.1161/HYPERTENSIONAHA.116.07861
   PubMed Web of Science ®Google Scholar
• Chen VC. Chao L and Chao J. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis. Biochim Biophys Acta. 2000;1479:237–246. doi:10.1016/S0167-4838(00)00044-3
   Web of Science ®Google Scholar
• Chen VC, Chao L, Chao J. Chao L and Chao J. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein. J Biol Chem. 2000;275(49):38457–38466. doi:10.1074/jbc.M005605200
   Web of Science ®Google Scholar
• Chen VC, Chao L, Pimenta DC, Bledsoe G, Juliano L, Chao J. Juliano L and Chao J. Identification of a major heparin-binding site in kallistatin. J Biol Chem. 2001;276(2):1276–1284. doi:10.1074/jbc.M005791200
   Web of Science ®Google Scholar
• Vilander LM, Kaunisto MA, Vaara ST, Pettilä V. Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock. Critical Care. 2017;21(1):47. doi:10.1186/s13054-017-1631-3
   Web of Science ®Google Scholar
• Madar T, Shahaf G, Sheiner E, et al. Holcberg G and Lewis EC. Low levels of circulating alpha-1 antitrypsin are associated with spontaneous abortions. J Matern Fetal Neonatal Med. 2013;26(18):1782–1787. doi:10.3109/14767058.2013.801955
   PubMed Web of Science ®Google Scholar
• Dean DD, Agarwal S, Tripathi P. Agarwal S and Tripathi P. Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages. J Assist Reprod Genet. 2018;35(12):2121–2128. doi:10.1007/s10815-018-1305-3
   Web of Science ®Google Scholar
• Yuan SM, Liao C, Li DZ, Huang JZ, Hu SY, Ke M. Zhong HZ and Yi CX. [Chorionic villus cell culture and karyotype analysis in 1 983 cases of spontaneous miscarriage]. Zhonghua Fu Chan ke Za Zhi. 2017;52:461–466. doi:10.3760/cma.j.issn.0529-567X.2017.07.006
   Google Scholar
• Magnus MC, Wilcox AJ, Morken NH. Weinberg CR and Haberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. doi:10.1136/bmj.l869
   PubMed Web of Science ®Google Scholar
• Nybo Andersen AM, Wohlfahrt J, Christens P. Olsen J and Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708–1712. doi:10.1136/bmj.320.7251.1708
   PubMed Web of Science ®Google Scholar
• Knudsen UB, Hansen V. Juul S and Secher NJ. Prognosis of a new pregnancy following previous spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 1991;39:31–36. doi:10.1016/0028-2243(91)90138-B
   PubMed Web of Science ®Google Scholar
• Haas DM. Hathaway TJ and Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Sys Rev. 2018;10:CD003511. doi:10.1002/14651858.CD003511.pub4
   PubMed Web of Science ®Google Scholar